CONMED CORP's ticker is CNMD and the CUSIP is 207410101. A total of 4 filers reported holding CONMED CORP in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,344,314 | -30.1% | 112,487 | -5.7% | 0.34% | -23.1% |
| Q2 2023 | $16,218,064 | +30.8% | 119,347 | -0.0% | 0.44% | +23.2% |
| Q1 2023 | $12,399,430 | +120517.0% | 119,386 | +2.9% | 0.36% | +11.2% |
| Q4 2022 | $10,280 | -99.9% | 115,979 | -2.9% | 0.32% | +3.9% |
| Q3 2022 | $9,571,000 | -20.6% | 119,386 | -5.2% | 0.31% | -14.6% |
| Q2 2022 | $12,057,000 | -35.6% | 125,906 | -0.0% | 0.36% | -18.1% |
| Q1 2022 | $18,708,000 | -2.3% | 125,940 | -6.8% | 0.44% | +15.4% |
| Q4 2021 | $19,148,000 | +11.5% | 135,073 | +2.9% | 0.38% | +7.9% |
| Q3 2021 | $17,180,000 | -19.4% | 131,312 | -15.3% | 0.36% | -6.8% |
| Q2 2021 | $21,316,000 | +0.7% | 155,103 | -4.3% | 0.38% | -2.6% |
| Q1 2021 | $21,167,000 | +2.3% | 162,090 | -12.3% | 0.39% | -0.3% |
| Q4 2020 | $20,689,000 | – | 184,719 | – | 0.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 1,385,000 | $58,862,000 | 5.19% |
| SIGNIA CAPITAL MANAGEMENT LLC | 146,589 | $6,230,000 | 2.32% |
| HEARTLAND ADVISORS INC | 1,773,782 | $75,386,000 | 1.31% |
| NORTH TIDE CAPITAL, LLC | 350,000 | $14,875,000 | 1.30% |
| Aurora Investment Counsel | 38,196 | $1,623,000 | 1.07% |
| INVESTMENT COUNSELORS OF MARYLAND LLC | 571,150 | $24,274,000 | 0.99% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 102,500 | $4,356,000 | 0.90% |
| Tributary Capital Management, LLC | 98,862 | $4,202,000 | 0.83% |
| PERKINS CAPITAL MANAGEMENT INC | 27,850 | $1,184,000 | 0.80% |
| Iguana Healthcare Management, LLC | 25,000 | $1,063,000 | 0.61% |